From the foods men eat to how surgery is planned and public awareness unfolds, new research presented at the American Urological Association (AUA) Annual Meeting in Washington, DC, shows prostate ...

Prostate cancer is one of the most frequently diagnosed cancers in men yet is often highly treatable when detected early. It originates in the prostate gland, located between the bladder and the penis ...

The statistics are sobering and undeniable — African American men develop prostate cancer at twice the rate of white men and are more likely to die from the disease. This reality makes understanding ...

Active surveillance is a standard approach for managing men with low‑risk prostate cancer to help delay or avoid treatment, but a significant number of patients eventually experience disease ...

Prostate cancer is among the most prevalent cancers in men, particularly above the age of 50. In India, prostate cancer has been increasingly reported, with the urban population being at a higher risk ...

The newly developed urine test helps identify which prostate cancer patients need a biopsy and which can safely skip the ...

Phase II ARASEC Data Further Supports the Efficacy and Safety of NUBEQA® (darolutamide) Plus ADT in Patients with mCSPC ...

Among prostate cancer patients under active surveillance, low testosterone levels were associated with a statistically significant increased risk of "extreme" progression to grade group 3 or higher ...

Talazoparib plus enzalutamide met the primary endpoint in TALAPRO-2, lowering radiographic progression or death risk by 37% versus enzalutamide, with median rPFS not reached. Efficacy signals extended ...